Stabilized amyloid-beta oligomers and uses thereof
US9556247B2 · kind B2 · utility
0Cited by
5References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2011 |
| Grant date | Jan 31, 2017 |
| Priority date | — |
| Expiry date | Sep 26, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K1/14
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention pertains to stabilized Aβ oligomer compositions. Methods for generating stabilized Aβ oligomer compounds are also provided herein. Additionally, screening assays employing the Aβ oligomer compounds and methods for generating therapeutics with the Aβ oligomers are also provided. In a particular embodiment, the Aβ oligomer described herein is comprised of Aβ42 peptide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.